AI assistant
Sending…
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2011
Jul 13, 2011
31049_dirs_2011-07-13_0351ff38-ded7-420d-b71c-87ce41f9866c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2006-12-04
Reporting Person: Nelson Arlin D (COO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, No Par Value | 903 | Indirect |
| Common Stock, No Par Value | 240 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Options (right to buy) | $12.14 | 2015-12-28 | Common Stock (10000) | Direct | |
| Non-qualified Stock Options (right to buy) | $15.03 | 2014-12-18 | Common Stock (10000) | Direct | |
| Non-qualified Stock Options (right to buy) | $13.81 | 2014-06-10 | Common Stock (1500) | Direct | |
| Non-qualified Stock Options (right to buy) | $21.67 | 2013-12-13 | Common Stock (3500) | Direct | |
| Non-qualified Stock Options (right to buy) | $9.74 | 2013-02-06 | Common Stock (8889) | Direct | |
| Non-qualified Stock Options (right to buy) | $7.61 | 2011-12-08 | Common Stock (8890) | Direct | |
| Non-qualified Stock Options (right to buy) | $2.07 | 2011-02-12 | Common Stock (8335) | Direct |
Footnotes
F1: Represents plan holdings as of December 6, 2006
F2: Become exercisable in equal annual installments of 20% commencing 2/12/2002
F3: Become exercisable in equal annual installments of 20% commencing 12/8/2002
F4: Become exercisable in equal annual installments of 20% commencing 2/6/2004
F5: Reflects shares owned by the reporting person and his spouse which were inadvertently omitted from the reporting person's Form 3, and were also omitted from Forms 4 filed by the reporting person subsequent to his original Form 3 filing.
More from MERIT MEDICAL SYSTEMS INC
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Share Issue/Capital Change
2026
May 15
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 13
M&A Activity
2026
Apr 1
Annual Report
2026
Mar 31